Skip to main content
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Online First
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Meg Barbor, MPH
Authored Items
HOPA Encourages Oncology Pharmacists to Deliver Patient Outreach Services
Meg Barbor, MPH
JHOP - June 2019 Vol 9, No 2
in
HOPA Highlights
Advances in Breast Cancer Treatments: Are We Extending Patients’ Survival?
Meg Barbor, MPH
JHOP - June 2019 Vol 9, No 2
in
HOPA Highlights
,
Breast Cancer
Role of Pharmacists in the Management of Chemotherapy-Induced Nausea and Vomiting
Meg Barbor, MPH
JHOP - June 2019 Vol 9, No 2
in
HOPA Highlights
Translating Cancer Genetics into Clinical Practice
Meg Barbor, MPH
JHOP - June 2019 Vol 9, No 2
in
HOPA Highlights
International Society of Cannabis Pharmacists Plans to Hold Inaugural Meeting in 2020
Meg Barbor, MPH
Web Exclusives
What’s New in the Oncology Drug Pipeline?
Meg Barbor, MPH
JHOP - June 2020 Vol 10, No 3
in
HOPA Highlights
,
Novel Pharmaceuticals
The Intersection of Immunotherapy and Targeted Therapy in Lung Cancer
Meg Barbor, MPH
JHOP - June 2020 Vol 10, No 3
in
HOPA Highlights
,
Biomarkers
,
Immunotherapy
,
Lung Cancer
The Cancer Care Gap in Rural America: A 50-Million People Conundrum
Meg Barbor, MPH
JHOP - June 2020 Vol 10, No 3
in
HOPA Highlights
,
Disparities in Oncology
Selecting Treatment for Relapsed/Refractory Multiple Myeloma in the Era of Multiple Choices
Meg Barbor, MPH
JHOP - December 2019 Vol 9, No 4
in
Multiple Myeloma
,
NCCN News
Biosimilars Are Key Components of Oncology Today: Brush Up on the Basics
Meg Barbor, MPH
JHOP - December 2019 Vol 9, No 4
in
NCCN News
What Is the Role of Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukemia?
Meg Barbor, MPH
JHOP - December 2019 Vol 9, No 4
in
Leukemia
,
NCCN News
Formal Hereditary Cancer Genetics Counseling Improves Patient Outcomes
Meg Barbor, MPH
Web Exclusives
Oral Cancer and Sex in the Era of HPV Infection
Meg Barbor, MPH
Web Exclusives
in
Head and Neck Cancer
Managing Bone Metastases Through a Multidisciplinary Approach
Meg Barbor, MPH
Web Exclusives
in
Supportive Care
Oral Toxicities Associated with Cancer Therapies: What's Old Is New Again
Meg Barbor, MPH
Web Exclusives
in
Drug Resistance
HOPA Conference Highlights
Meg Barbor, MPH
JHOP - December 2016 Vol 6, No 4
Challenges in ALK-Positive NSCLC Management
Meg Barbor, MPH
Web Exclusives
Lowering the High Cost of USP 800 Compliance
Meg Barbor, MPH
Web Exclusives
Last modified: February 13, 2020
